An open-label phase 1 dose-escalation clinical trial to determine the maximally tolerated dose and dose-limiting toxicities of a single intravenous gemcitabine administration in dogs with advanced solid tumors / Beatrice L, Finotello R, Dacasto M, Bonfanti U, Aresu L, Leone V, Pizzoni S, Furlanello T, Balestra G, Rohrer-Bley C, Marconato L.. - STAMPA. - (2014), pp. 60-60. (Intervento presentato al convegno ESVONC Annual Congress tenutosi a Vienna, Austria nel May 22nd- 24th, 2014).
An open-label phase 1 dose-escalation clinical trial to determine the maximally tolerated dose and dose-limiting toxicities of a single intravenous gemcitabine administration in dogs with advanced solid tumors.
Marconato L.
2014
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.